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Abstract
There is increasing evidence of an association between a low maternal vitamin D status and a high risk of adverse pregnancy outcomes.
In a cross-sectional study, we investigated the vitamin D status of pregnant women to determine potentially influencing factors. Between
December 2010 and February 2012, 261 maternal blood samples and 328 cord blood samples were collected for the analysis of
25-hydroxyvitamin D (25(OH)D), intact parathyroid hormone, alkaline phosphatase and Ca concentrations. Demographical characteristics
and clinical data were recorded by a questionnaire and from medical files. The overall median maternal and cord blood 25(OH)D levels
were 25·0 (interquartile range 12·6–45·5) nmol/l and 34·1 (interquartile range 17·7–58·6) nmol/l, respectively. During the winter months,
98 % of the maternal blood samples and 94 % of the cord blood samples had 25(OH)D levels ,50 nmol/l. In the summer months, 49 % of
the women and 35 % of the cord blood samples were vitamin D deficient. Using logistic regression models, significant risk factors for maternal
vitamin D deficiency were found to be physical inactivity (adjusted OR (aOR) 2·67, 95 % CI 1·06, 6·69, P¼0·032) and a non-European country
of origin (aOR 3·21, 95 % CI 1·0, 10·28, P¼0·047) after controlling for season and independent risk factors. These results are the first 25(OH)D
data for pregnant women in Germany. They indicate the need for urgent implementation of strategies to prevent vitamin D deficiency by
healthcare authorities that are in charge of preventing vitamin D deficiency, especially during these sensitive stages of life.
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Vitamin D deficiency has become a worldwide public health
problem(1). There is increasing evidence of an association
between a low maternal vitamin D status, evaluated by
25-hydroxyvitamin D (25(OH)D) concentration, and a high
risk of pre-eclampsia(2,3), gestational diabetes(4,5) and infec-
tious disease(6,7) as well as an increased risk of reduced fetal
bone mineral accrual(8–10) and respiratory infections and
wheezing(11,12) in infants.
In addition, non-skeletal health effects have been found,
but so far only in observational studies; their causality and sig-
nificance need to be proven by randomised controlled trials(13).
Due to the remarkable high prevalence of vitamin D deficiency,
the possible health consequences should not be under-
estimated as it has been shown that rickets is on the rise in
developed as well as developing countries(14,15).
The supply of vitamin D is primarily dependent on sunlight
exposure, in particular on UVB irradiation (290–315 nm), of
the skin, whereas the intake via food is only of marginal
importance(14). The efficiency of vitamin D that is produced
in the skin depends on skin melanin pigmentation(14,16),
age(17), sunscreen use(18) or clothing, including veiling(19), as
well as on latitude and season(14,20). In Europe and in many
other parts of the world at a latitude above 358 of the northern
or southern hemisphere, it has been shown that UVB
irradiation is not sufficient for the synthesis of necessary
amounts of vitamin D from November to March(20–22). We
hypothesise that pregnant women and their newborns living
in Germany at latitudes between 54 and 478N are at a high
risk of vitamin D deficiency at delivery.
During the last couple of years, a number of studies inves-
tigating the vitamin D status of pregnant women have shown
a high variation in the prevalence of vitamin D deficiency
worldwide, ranging between 5 and 96 %(19,23–31). This
variation might be due to the divergent cut-off values and
analytical methods that are applied in different studies as
well as to the geographical and habitual disparities between
countries. For example, there are different proportions of
individuals who wear a veil as well as variations in the
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national law regulating food fortification. In Europe, the
fortification of food with vitamin D is more common in the
Nordic countries, including Norway, Denmark and Sweden,
than in Central or Southern European countries(32).
Hence, we assume that there is also a need to determine
country-specific prevalence data. Especially in Germany, to
our knowledge, no data are available concerning the
vitamin D status of pregnant women based on the analysis of
the 25(OH)D level. The objective of the present study was to
estimate the 25(OH)D status and possible risk factors for vita-
min D deficiency in a cohort of German pregnant women
and in cord blood. Our data should help to improve the clinical
practice of healthcare authorities regarding the prevention of
vitamin D deficiency during pregnancy and infancy.
Patients and methods
Study design and setting
The present cross-sectional study was conducted between
December 2010 and February 2012 at the maternity unit of
St Josefs Hospital, a general community care hospital with
more than 1000 births per year, located in Giessen, Germany,
at a latitude of 508N. The present trial was registered at the
German Clinical Trials Register (DRKS-ID: DRKS00003245).
Study population
On the first day of their admittance to the hospital, a total of
369 women gave written informed consent to participate in
the study. Exclusion criteria were a chronic liver or kidney
disease, secondary hyperparathyroidism or malabsorption
diseases and an intake of medications that are known to
affect vitamin D metabolism, including glucocorticoids and
anticonvulsants. All women completed a self-administered
questionnaire. A total of 261 women (71 %) provided a
single blood sample for 25(OH)D analysis and a total of 328
women (89 %) gave their consent for the analysis of a single
cord blood sample. Hence, it was possible to match a total
of 220 mother–infant pairs. Of the 328 newborns, five were
sent to the Neo-Intensive Care Unit, due to low base excess
levels in cord blood, dyspnoea (mask respiration required),
a pH in cord artery ,7·0, infections or cardiac arrhythmia.
A single maternal blood sample was drawn either at the
time of delivery or within 72 h post-partum. A single cord
blood sample was drawn at delivery. Blood samples were
collected using S-Monovette lithium heparin 7·5 ml tubes
(Sarstedt Monovette) and kept at 48C for a maximum of 4 h
until centrifugation. Plasma was removed and stored at
2808C until analysis. The samples were assayed at the end
of a sampling period and defined according to the season of
sampling as follows: winter (December to February); spring
(March to May); summer (June to August); autumn (September
to November). The samples were sent to a central clinical
laboratory in Cologne on dry ice. The laboratory participates
in national and international quality assurance schemes and
is fully accredited according to the DIN EN ISO 17 025 and
DIN EN ISO 15 189.
Laboratory analysis
Total 25(OH)D concentration was measured by a direct
competitive fully automated chemiluminescent immunoassay
(LIAISON 25 OH Vitamin D TOTAL assay; DiaSorin). This
standardised assay predicates on the same specificity and
analytical sensitivity as the DiaSorin RIA, which was used to
establish 25(OH)D reference values for clinical practice(33,34).
The functional sensitivity of the assay is ,10·0 nmol/l
(to convert to ng/ml, divide by 2·5) and the analytical range
is 10·0–375·0 nmol/l. The intra- and inter-assay CV were ,3
and ,13 % in a concentration range of 18·0–87·5 nmol/l.
The assay has a cross-reactivity of 100 % to 25(OH)D2 and
of 104 % to 25(OH)D3. The laboratory reference value for
an optimal 25(OH)D level for healthy female adults is
$50 nmol/l. Key parameters of bone metabolism were inves-
tigated by the analysis of intact parathyroid hormone (iPTH),
alkaline phosphatase and Ca concentrations. iPTH concen-
tration was determined by a chemiluminescent immunoassay
(LIAISON N-TACT PTH assay; DiaSorin). The intra- and inter-
assay CV were #8 and ,14 % in a concentration range
of 7·80–5·10 pg/ml, respectively. The analytical range is
5·0–400·0 pg/ml. The laboratory reference range for healthy
female adults is 7·0–82·0 pg/ml. Total Ca and alkaline phos-
phatase concentrations were measured by photometric or
kinetic colour testing using Olympus automated analysers
(Olympus AU640 and AU600; Lismeehan Company).
Definition of vitamin D deficiency cut-offs
Vitamin D status can be evaluated by measuring the con-
centration of the major circulating vitamin D metabolite,
25(OH)D, reflecting dietary intake and endogenous
production(34,35).
For Ca and bone metabolism, it has been well described
that at 25(OH)D levels ,50 nmol/l, the PTH concentration
starts to increase rapidly, whereas it begins to plateau
at 25(OH)D levels .75 nmol/l(36,37). Consequently, the risk
of bone resorption and secondary hyperparathyroidism is
increased(38,39). With regard to the non-classical effects of
vitamin D, there are observations indicating that 25(OH)D
levels of 50 nmol/l or less are associated with major clinical
diseases(40). Therefore, we used 50 nmol/l as the vitamin D
deficiency cut-off, which is currently being proposed by a
number of authorities, for example the International Osteo-
porosis Foundation, the Canadian Osteoporosis Society and
the Endocrine Society(41–43).
Assessment of secondary outcome measures
Women had to complete a questionnaire to record factors that
have been shown to be associated with the 25(OH)D level,
including baseline demographics and habitual and health-
related variables(44). Data of the medical history of each
participant were determined by the external quality assurance,
a standardised form routinely used in St Josefs Hospital to
assess anthropometric, medical and socio-economic data for
general statistical reasons.
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The recorded demographical and habitual variables were
statistically considered as independent variables (independent
risk factors) and dichotomised as follows: age by median
(#30 or 31–40 years); pre-pregnancy BMI calculated from
height and pre-pregnancy weight that was recorded from
the external quality assurance and classified using the WHO
cut-off for overweight (#25 or .25 kg/m2)(45); parity, i.e.
number of previous pregnancies (nulliparous or $1 para);
country of origin (European and non-European or other
countries of origin); type of skin (light or medium–dark,
modified by Fitzpatrick(46)); wearing a veil (yes or no); years
spent at school (no degree, ,8 years or $10 years); physical
activity (,1 or $1 h/week), i.e. referring to an average physi-
cal activity load during pregnancy; time spent outdoors (,1 or
$1 h/d). The intake and frequency of vitamin D-containing
supplements were assessed by asking whether the women
had taken a vitamin D-containing supplement or other sup-
plements during pregnancy or not and, if yes, what the
brand name was. Questions to assess health-related variables
included those on malabsorption disease, including ulcerative
colitis, Crohn’s disease, allergies, diabetes mellitus, asthma and
the use of medications that are known to affect vitamin D
metabolism, including glucocorticoids and anticonvulsants.
Data of the medical history and baseline characteristics of
women and their newborns were recorded from the external
quality assurance.
The present study was conducted according to the guide-
lines laid down in the Declaration of Helsinki, and all
procedures involving human subjects were approved by the
local ethics committee of the medical department of the
Justus Liebig University Giessen (AZ 189/10).
Sample size calculation and statistical analysis
Using a paired t test for independent samples, we estimated
that with 300 subjects (seventy-five pregnant women and
newborns per season), we would have 80 % statistical power
at a two-sided significance level of a ¼ 0·05 to detect a mini-
mal difference of 7 nmol/l between the true value of the
median 25(OH)D concentration and the sample median in
our cohort considering a standard deviation of 10 nmol/l,
according to the literature(47–49).
To take into account the absence of a Gaussian distri-
bution, an additional 10 % was considered in the sample
size calculation. Normality tests were carried out using the
Shapiro–Wilk test. Non-normally distributed data are shown
as medians with interquartile ranges. Comparisons of medians
for non-normally distributed data were carried out using non-
parametric tests including either the Kruskal–Wallis test in
conjunction with the Mann–Whitney U test as a post hoc test
and a Bonferroni corrected P value ,0·016 or the Wilcoxon
signed rank test. The Mann–Whitney U test was used to test
for significant differences between two independent samples.
Yates’ correction was used where appropriate. Correlations
between continuous variables were assessed using Spearman’s
rank coefficient of correlation (rs ).
Table 1. Maternal 25-hydroxyvitamin D (25(OH)D) levels for the total cohort (n 261), intact
parathyroid hormone (iPTH), alkaline phosphatase (ALP) and calcium levels for the number of
available samples, and cord blood 25(OH)D levels for the total cohort (n 328)
(Medians and interquartile ranges (IQR); number of subjects and percentages)
25(OH)D (nmol/l)
Parameters ,50 nmol/l $50 nmol/l P *
Maternal 25(OH)D (nmol/l) ,0·001
% 77 23
n 261 201 60
Median 25·0 18·8 65·6
IQR 12·6–45·5 11·4–30·6 54·4–73·9
iPTH (pg/ml) ,0·001
% 75 25
n 214 160 54
Median 37·30 45·60 16·71
IQR 18·78–58·65 27·43–65·50 9·98–24·73
ALP (mkat/l) 0·519
% 76 24
n 239 181 58
Median 2·68 2·70 2·65
IQR 2·20–3·24 2·22–3·22 2·09–3·28
Ca (mmol/l) 0·205
% 73 22
n 200 145 55
Median 2·30 2·31 2·30
IQR 2·21–2·42 2·20–2·40 2·31–2·43
Cord blood 25(OH)D (nmol/l) ,0·001
% 69 31
n 328 226 102
Median 34·1 22·4 74·5
IQR 17·7–58·6 13·0–35·6 61·3–94·4
*P value for the Mann–Whitney U test comparing medians between 25(OH)D categories.
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Univariate, bivariate and multivariate logistic regression
models were used to estimate the crude and adjusted OR
with 95 % CI for vitamin D deficiency, using the 25(OH)D
level as a dichotomous categorical variable and the proposed
risk factors as independent variables. A two-sided P value
,0·05 was considered as statistically significant and only vari-
ables with P,0·05 in the univariate logistic regression analysis
were included in the final multivariate model. All analyses
were conducted using the IBM SPSS statistics version 20.
Results
In the present study, 77% of the maternal blood samples and
69 % of the cord blood samples had 25(OH)D levels
,50 nmol/l. The overall median maternal and cord blood
25(OH)D levels were 25·0 (interquartile range 12·6–45·5)
and 34·1 (interquartile range 17·7–58·6) nmol/l, respectively
(Table 1).
Women who were from a non-European country, who were
physically active ,1 h/week, who spent ,1 h/d outdoors or
had $1 previous pregnancy had significantly lower median
25(OH)D levels than those from a European country of
origin with a physical activity level $1 h/week and those
who spent $1 h/d outdoors (Table 2).
Considering 50 nmol/l as the cut-off, 98 % of the maternal
blood samples and 94 % of the cord blood samples had
25(OH)D concentrations below this level in winter (Fig. 1).
Even during the summer months, 49 % of the maternal
blood samples and 35 % of the cord blood samples had
25(OH)D concentrations under this threshold.
Overall, a strong positive correlation between the maternal
and cord blood 25(OH)D levels could be observed (rs 0·93,
P,0·001; Fig. 2). Median maternal and cord blood 25(OH)D
levels were significantly different between the seasons, with
the highest median maternal levels being observed in
summer (50·5 (interquartile range 30·4–66·2) nmol/l) and the
lowest in winter (11·8 (interquartile range 10·0–17·8) nmol/l).
The same seasonal variation was observed for the cord
blood 25(OH)D levels. Median 25(OH)D levels were 61·4
(41·5–87·5) nmol/l in summer and 16·3 (10·0–26·8) nmol/l in
winter (Bonferroni corrected P,0·001). Data are given in the
Supplementary material (available online).
In the following, we discuss only maternal biochemical
parameters (Table 1). We found a significantly inverse
correlation of maternal 25(OH)D and iPTH levels (rs 20·6,
P,0·001). Vitamin D-deficient women had significantly
higher median iPTH levels than those with 25(OH)D levels
$50 nmol/l (45·60 (interquartile range 27·43–65·50) pg/ml
and 16·71 (interquartile range 9·98–24·73) pg/ml,
respectively; P,0·001). Ca and alkaline phosphatase levels
showed a significantly positive correlation with 25(OH)D
levels (rs 0·33, P,0·001, and rs 0·19, P,0·05, respectively).
The Ca level was significantly inversely correlated with the
iPTH level (rs20·39, P,0·001).
When using a univariate logistic regression analysis to
calculate crude OR and 95 % CI, a significant association
between maternal vitamin D deficiency and season, a non-
European country of origin, physical inactivity ,1 h/week,
pre-pregnancy BMI .25 kg/m2, no vitamin D supplement
intake, parity ($1 previous pregnancy) and the iPTH level
Table 2. 25-Hydroxyvitamin D (25(OH)D) levels (nmol/l) of pregnant women (n 261) according to the demographical
characteristics
(Medians and interquartile ranges (IQR); number of subjects and percentages)
25(OH)D (nmol/l)
,50 nmol/l $50 nmol/l
Parameters n Median IQR % n % n P †
Country of origin 246 0·007
European 177 26·8 14·6–51·4 73 129 27 48
Non-European 69 19·8*** 10·0–35·0 90 62 10 7
Physical activity (h/week) 256 ,0·001
, 1 137 20·0*** 10·9–35·8 85 117 15 20
$ 1 119 36·5 17·6–56·3 67 80 33 39
Time spent outdoors (h/d) 256 0·132
, 1 50 20·0* 10·0–37·6 86 43 14 7
$ 1 206 25·6 15·0–50·5 75 154 25 52
Pre-pregnancy BMI (kg/m2) 247 0·065
# 25 172 26·6 14·4–51·8 72 124 28 48
. 25 75 21·3 12·0–42·8 84 63 16 12
Age by median (years) 261 0·74
# 30 143 25·3 13·9–46·0 76 109 24 34
31–40 118 24·8 12·4–44·5 78 92 22 26
Parity 260 0·121
Nulliparous 131 27·0* 16·3–52·3 72 95 28 36
$ 1 Previous pregnancy 129 21·3 11·3–42·8 81 105 19 24
Type of skin 258 0·325
Light 100 26·4 17·7–17·5 80 80 20 20
Medium–dark 158 21·6 11·5–50·5 75 118 25 40
Median values were significantly different between categories by the Mann–Whitney U test: *P , 0·05, ***P , 0·001.
†P value for the x 2 test or Fisher’s exact test for categorical variables.
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could be observed (Table 3). Season itself had the strongest
effect on maternal 25(OH)D levels (OR 47·07, 95 % CI 10·76,
205·75, P,0·001; Table 3). The risk of 25(OH)D levels
,50 nmol/l during winter was forty-seven times as high as
that during summer. The OR for spring was 5·2 (95 % CI
2·27, 11·79, P,0·001) and for autumn, it was 2·7 (95 % CI
1·2, 6·2, P¼0·02).
In the multivariate logistic regression analysis controlling for
season and significant independent risk factors (e.g. vitamin D
supplement intake, pre-pregnancy BMI, parity and time
spent outdoors as categorical variables as well as the iPTH
level as a continuous variable), physically inactive women
were about 2·7 times more likely to have vitamin D deficiency
than those reporting to be physically active $1 h/week
(adjusted OR 2·67, 95 % CI 1·06, 6·69, P¼0·032). Women
from a non-European country of origin had 3·2 times the
odds of being vitamin D deficient than those from a European
country of origin (adjusted OR 3·21, 95 % CI 1·0, 10·28,
P¼0·047; data not shown).
No correlation with vitamin D status was found for the time
spent outdoors, age, type of skin and years spent at school
analysed as continuous and categorical variables.
Discussion
To our knowledge, the present results are the first 25(OH)D
data to be presented for pregnant women living in Germany.
From previous studies, we know that, especially during
winter, there is a high risk of vitamin D deficiency for the gen-
eral population(19,50). However, the very high prevalence in
our cohort had not been expected, and the results support
our hypothesis that pregnant women are at a high risk of vita-
min D deficiency at the time of delivery. Our data are based
on a 25(OH)D cut-off of 50 nmol/l as recommended by
various authorities(41–43). In 2011, the North American Insti-
tute of Medicine released a report on the dietary reference
intakes for Ca and vitamin D, considering a 25(OH)D level
,30 nmol/l as vitamin D deficiency(51). On applying their
recommendation to our data, the prevalence of vitamin D
deficiency did not change much. For example, during the
winter months, 92 % of the maternal blood 25(OH)D levels
and 79 % of the cord blood 25(OH)D levels were ,30 nmol/l.
Like in many other countries, the German Nutrition Society
has recently changed the dietary reference intake for vitamin D
for different population groups(52). For pregnant women,
the recommendations were set to 20mg vitamin D/d com-
pared with the former 5mg/d. This seems to be a major step
towards improving the vitamin D status. However, these
dietary reference intakes include the following statement of
limitation: 20mg vitamin D/d are only recommended if there
is no cutaneous synthesis of vitamin D(52). From a practical
point of view, we are convinced that this is difficult to
comply with: how should an individual know how much
vitamin D he or she should take? The endogenous vitamin D
synthesis after exposure to sunlight can hardly be estimated
without measuring the 25(OH)D level. Consequently, we
suspect that there will be no improvement of the current
vitamin D supply, with respect to not only pregnant women,
but also the vast majority of the population.
After adjusting for independent risk factors, we identified
physical inactivity (,1 h/week) and a non-European country
of origin as risk factors for maternal vitamin D deficiency,
25(OH)D , 50 nmol/l. Within the scope of the questionnaire,
the actual sunlight exposure (time spent outdoors) as well as
the exact load of physical activity was not determined.
Furthermore, at the end of pregnancy, the extent of physical
activity is very likely to decrease. Hence, only a very conser-
vative conclusion can be drawn from these results, as the
use of a questionnaire is always highly susceptible to recall
bias by the participants.
To determine risk factors for vitamin D deficiency, we
adjusted our data for the season of blood sampling. As
expected, season itself had the strongest effect on maternal
25(OH)D levels (OR 47·07, 95 % CI 10·76, 205·75, P,0·001;
Table 3).
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in pregnant women (n 261, ) and in cord blood (n 328, ), stratified by
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We also found that at normal Ca levels, vitamin D-deficient
women had significantly higher median iPTH levels than those
with a 25(OH)D level .50 nmol/l, indicating an increased risk
of bone demineralisation. These findings could be seen as a
metabolic compensation due to the low 25(OH)D level. PTH is
strongly involved in Ca and vitamin D metabolism. Vitamin D
deficiency or slightly decreased Ca levels stimulate PTH secretion
andcancause secondaryhyperparathyroidism.Consequently,Ca
is mobilised from the bones, which might have various health
impacts including an increased risk of osteoporosis as well as
impairedbonemineralisation(48,53,54). In addition, thedeveloping
fetus is strongly dependent on maternal placental Ca and
25(OH)D transfer(54). It is assumed that the circulating 25(OH)D
crosses the placenta readily, whereas the active hormone, 1,25-
dihydroxyvitamin D3, does not. Consequently, the formation of
1,25-dihydroxyvitamin D3 in the fetal kidney is exclusively
dependent on the maternal substrate that crosses the placenta
and hence the maternal 25(OH)D level(55–58).
We observed significantly higher median cord blood
25(OH)D levels compared with the maternal levels, which
differ from most of the published data (e.g. Dror et al.(8)).
However, results from other studies are consistent with our
observations. In their review from 2010, Dror & Allen(59)
stated that the 25(OH)D level in cord blood at delivery may
range from 68 to 108 % of maternal levels. Significantly
lower median maternal 25(OH)D levels compared with cord
blood levels have also been reported by others(47–49); the
reasons for the discrepancies are not known yet. There
might be a link with the C-3 epimer concentration of the
25(OH)D molecule that has been shown to be present
especially in cord blood. However, the chemiluminescent
immunoassay LIAISON method that we used is not affected
by the C-3 epimer(60,61).
In the present study, vitamin D supplement intake was not
related to vitamin D status after controlling for season. This
might be explained by the low number of pregnant women
reporting the intake of supplements. Only 20 % of the
women stated that they took a vitamin D-containing sup-
plement. Despite a daily supplement intake in the range of
0·14–25mg, the majority of these women still showed
vitamin D deficiency. The same was true for veiling as a
possible risk factor for vitamin D deficiency. In our cohort,
only 3 % of the women were wearing a veil, which included
eight women in total. Due to the low sample size, this risk
factor was excluded from the present analysis. The type
of skin did not significantly influence maternal 25(OH)D
levels.
We would like to mention that the present study had some
limitations. It was only possible to determine the vitamin D
status of women at the end of pregnancy. 25(OH)D concen-
trations at the beginning of pregnancy and during the whole
gestation should be investigated in future studies. Further-
more, due to a lack of blood volume and due to the short
half-life of iPTH, it was not possible to measure iPTH,
alkaline phosphatase and Ca concentrations in all the 261
women. Data on the modifiable factors, including the ident-
ified risk factors physical activity and country of origin,
were determined by a self-administered questionnaire,
which is prone to recall bias. Furthermore, questions con-
cerning vitamin D intake from food, physical outdoor activity,
visit to a solarium, holidays per year and use of sunscreen
(sun cream per d) had to be excluded from the analysis
due to incomplete or missing answers. In a prospective
approach, a more controlled setting is desirable to obtain
more definite answers.
In conclusion, to our knowledge, these results are the first
data to be presented for Germany, showing that an extremely
high number of pregnant women and their newborns are
prone to severe vitamin D deficiency, almost regardless of
season. The present results clearly indicate that there is a
great need for urgent action especially by public healthcare
authorities that are in charge of preventing vitamin D
deficiency during sensitive stages of life. The daily intake of
vitamin D should be increased considerably; however, its
extent needs to be clarified in future studies. Only recently,
the European Food Safety Authority(62) has increased the toler-
able upper intake level of vitamin D for adults including
pregnant and lactating women from 50 to 100mg/d. This
amount is far beyond the current dietary reference intake in
Germany and many countries worldwide.
Table 3. Factors associated with maternal vitamin D deficiency (25-hydroxyvitamin D (25(OH)D) ,50 nmol/l)
(Crude and adjusted odds ratios with 95 % confidence intervals)
Factors OR 95 % CI P † aOR 95 % CI P ‡
Non-European country of origin 3·27 1·11, 7·72 0·006 3·09 1·22, 7·73 0·016
Physical inactivity (,1 h/week) 2·85 1·55, 5·25 0·001 2·53 1·26, 5·03 0·008
iPTH (pg/ml) 1·07 1·04, 1·09 ,0·001 1·04 1·01, 1·06 0·002
Pre-pregnancy BMI (.25 kg/m2) 2·03 1·00, 4·09 0·048 1·72 0·79, 3·74 0·169
Parity ($1 previous pregnancy) 1·85 1·03, 3·34 0·041 1·78 0·87, 3·34 0·117
No vitamin D supplement intake 2·04 1·03, 4·01 0·040 1·85 0·84, 4·06 0·125
Season (winter)* 47·07 10·76, 205·75 ,0·001 – – –
Time spent outdoors (,1 h/d) 2·10 0·88, 4·89 0·096 1·51 0·57, 3·94 0·398
Age (.30–40 years) 1·10 0·61, 1·97 0·739 1·10 0·56, 2·13 0·775
Type of skin (medium–dark) 1·35 0·73, 2·48 0·326 1·70 0·85, 3·35 0·127
Years spent at school (no degree, ,8 years) 3·19 0·93, 10·87 0·064 3·73 0·97, 14·29 0·055
OR, crude OR; aOR, adjusted OR; iPTH, intact parathyroid hormone.
* Reference category for season is summer.
†P value for the univariate logistic regression analysis.
‡P value for the bivariate logistic regression analysis controlling for season (categorical).
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